Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications

Item

http://www.wikidata.org/entity/Q37227240

Q37227240

about

Cytomegalovirus infection in transplant recipients Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.CMV-specific immune reconstitution following allogeneic stem cell transplantation.Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies.Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation.Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection.Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation

P2860

Q26801802-071E60CD-56E2-442B-861E-D83F461AC318 Q35760200-1BD14818-BCBB-405B-8E8F-76AC0B4C2A11 Q37242592-C7C06EC8-5360-4A9A-A387-F718A099241B Q37504023-91424ECB-1614-41E5-A694-49243A354249 Q37509207-53F62CD3-F453-415C-BE55-29769133B62F Q37652611-0F975958-F84D-4060-B482-1575BF0D3B83 Q37683007-0432C0ED-310C-446E-B1ED-FB35DE881939 Q38547042-6399FB9D-15C9-4B18-AFF5-826A6B8F239A Q38856032-FCE9E71F-3789-42F6-A9FD-4BC23F3EDA46 Q38942459-D966C9BC-BDF2-41E3-A277-6A0A05FC7B23 Q40163004-C5F0F67D-05F6-4378-B105-DFA652F63A38 Q40232782-ED228FA3-0FBF-4A78-9C3A-55C349D9BBF4 Q40355635-C42D29F7-74EC-45AD-952A-62095515B7A2 Q41684129-9A5153C3-8126-494E-87DB-6F901661EE2A Q43577477-D6A94F6C-6555-41F5-ABF0-0EE8FDA1769D Q47136178-D686CA01-576D-4E49-8DE4-602868EF0364 Q47557661-F5F9F34D-4784-4723-AA0C-D4DB3349CA07 Q52367953-2C726CF9-7139-4860-8741-49679E2066B9 Q57053200-634153DE-9CB3-4C86-BBBC-9D4EF73E7A33

P2860

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications

Item

http://www.wikidata.org/entity/Q37227240

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical assessment of anti-vi ...... th CMV infection complications

@en

Clinical assessment of anti-vi ...... h CMV infection complications.

@nl

type

Item

label

Clinical assessment of anti-vi ...... th CMV infection complications

@en

Clinical assessment of anti-vi ...... h CMV infection complications.

@nl

prefLabel

Clinical assessment of anti-vi ...... th CMV infection complications

@en

Clinical assessment of anti-vi ...... h CMV infection complications.

@nl

P1476

Clinical assessment of anti-vi ...... th CMV infection complications

@en

P2093

Ashish K Misra

http://www.w3.org/2001/XMLSchema#string

Glen A Kennedy

http://www.w3.org/2001/XMLSchema#string

James A Morton

http://www.w3.org/2001/XMLSchema#string

Jason P Butler

http://www.w3.org/2001/XMLSchema#string

Linda I Jones

http://www.w3.org/2001/XMLSchema#string

Simon T Durrant

http://www.w3.org/2001/XMLSchema#string

Susan Walker

http://www.w3.org/2001/XMLSchema#string

Tania Crough

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study.

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy.

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Immunobiology of human cytomegalovirus: from bench to bedside.

Human cytomegalovirus genome.

Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

P304

e74744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0074744

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258066144

http://www.w3.org/2001/XMLSchema#string

P698

24146744

http://www.w3.org/2001/XMLSchema#string

P932

3795724

http://www.w3.org/2001/XMLSchema#string

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications

about

P2860

P2860

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932